Good Results for Bone Drug Buoy Amgen
Friday, September 19, 2008 - 00:50
in Health & Medicine
Amgen’s experimental bone drug reduced the risk of spinal fractures in women with osteoporosis by 68 percent in a pivotal clinical trial.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Healthy bones program reduces hip fractures by 37 percentTue, 4 Nov 2008, 15:49:27 EST
- ACP issues guideline for drug treatment of men and women with osteoporosis or low bone densityTue, 16 Sep 2008, 13:30:05 EDT
- Wrist fracture patients less likely to be evaluated for osteoporosisThu, 1 Oct 2009, 10:24:35 EDT
- Why binge drinking is bad for your bonesThu, 23 Oct 2008, 11:43:15 EDT
- Prevent a bone break, drink milk to boost calciumMon, 9 Jun 2008, 12:42:41 EDT